Please assess the completion status of the following clinical trial:

Trial Title: Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~1. Healthy male and female adults~2. Aged 65 to 85 years~Exclusion Criteria:~1. Proven or suspected prior episode of Clostridium difficile associated diarrhea~2. Unstable chronic medical condition~3. Disease requiring significant change in therapy or hospitalization for worsening disease within 8 weeks before receipt of study vaccine~4. Serious chronic medical disorders~5. Bleeding diathesis or condition associated with prolonged bleeding time that may contraindicate intramuscular injection~6. Any contraindication to vaccination or vaccine components, including previous anaphylactic reaction to any vaccine or vaccine-related components~7. Subjects with congenital or acquired immunodeficiency disorders~8. Subjects with rheumatologic disorders or other illnesses requiring chronic treatment with known immunosuppressant medications~9. Active or treated leukemia or lymphoma or bone marrow disorder~10. Residence in a nursing home or other long-term care facility, or requirement for semiskilled nursing care or assisted living~11. Abnormality in screening hematology and/or blood chemistry laboratory values

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- Low-dose C. difficile Vaccine (accelerated schedule) (Type: EXPERIMENTAL): None
- High-dose C. difficile Vaccine (accelerated schedule) (Type: EXPERIMENTAL): None
- Placebo (accelerated schedule) (Type: PLACEBO_COMPARATOR): None
- Low-dose C. difficile Vaccine (non-accelerated schedule) (Type: EXPERIMENTAL): None
- High-dose C. difficile Vaccine (non-accelerated schedule) (Type: EXPERIMENTAL): None
- Placebo (non-accelerated schedule) (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).